These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21890590)

  • 21. Spontaneously Hypertensive Rats (SHR) present deficits in prepulse inhibition of startle specifically reverted by clozapine.
    Levin R; Calzavara MB; Santos CM; Medrano WA; Niigaki ST; Abílio VC
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1748-52. PubMed ID: 21693159
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Iloperidone reduces sensorimotor gating deficits in pharmacological models, but not a developmental model, of disrupted prepulse inhibition in rats.
    Barr AM; Powell SB; Markou A; Geyer MA
    Neuropharmacology; 2006 Sep; 51(3):457-65. PubMed ID: 16762376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroleptic effects on P50 sensory gating in patients with first-episode never-medicated schizophrenia.
    Hong X; Chan RC; Zhuang X; Jiang T; Wan X; Wang J; Xiao B; Zhou H; Jiang L; Weng B
    Schizophr Res; 2009 Mar; 108(1-3):151-7. PubMed ID: 19106034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDP-choline: effects of the procholine supplement on sensory gating and executive function in healthy volunteers stratified for low, medium and high P50 suppression.
    Knott V; Smith D; de la Salle S; Impey D; Choueiry J; Beaudry E; Smith M; Saghir S; Ilivitsky V; Labelle A
    J Psychopharmacol; 2014 Dec; 28(12):1095-108. PubMed ID: 25315828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Amphetamine on Sensorimotor Gating and Neurocognition in Antipsychotic-Medicated Schizophrenia Patients.
    Swerdlow NR; Bhakta SG; Talledo JA; Franz DM; Hughes EL; Rana BK; Light GA
    Neuropsychopharmacology; 2018 Mar; 43(4):708-717. PubMed ID: 29154367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of Prepulse Inhibition (PPI) after neonatal excitotoxic lesion of the ventral thalamus in pubertal and adult rats.
    Wolf R; Matzke K; Paelchen K; Dobrowolny H; Bogerts B; Schwegler H
    Pharmacopsychiatry; 2010 May; 43(3):99-109. PubMed ID: 20131206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The neurotensin agonist NT69L improves sensorimotor gating deficits in rats induced by a glutamatergic antagonist, but not by dopaminergic agonists.
    Secchi RL; Sung E; Hedley LR; Button D; Schreiber R
    Behav Brain Res; 2009 Sep; 202(2):192-7. PubMed ID: 19463701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine agonist effects on startle and sensorimotor gating in normal male subjects: time course studies.
    Swerdlow NR; Eastvold A; Karban B; Ploum Y; Stephany N; Geyer MA; Cadenhead K; Auerbach PP
    Psychopharmacology (Berl); 2002 May; 161(2):189-201. PubMed ID: 11981599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric alpha-7 nicotinic receptor modulation and P50 sensory gating in schizophrenia: a proof-of-mechanism study.
    Winterer G; Gallinat J; Brinkmeyer J; Musso F; Kornhuber J; Thuerauf N; Rujescu D; Favis R; Sun Y; Franc MA; Ouwerkerk-Mahadevan S; Janssens L; Timmers M; Streffer JR
    Neuropharmacology; 2013 Jan; 64():197-204. PubMed ID: 22766391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Short-term tropisetron treatment and cognitive and P50 auditory gating deficits in schizophrenia.
    Zhang XY; Liu L; Liu S; Hong X; Chen DC; Xiu MH; Yang FD; Zhang Z; Zhang X; Kosten TA; Kosten TR
    Am J Psychiatry; 2012 Sep; 169(9):974-81. PubMed ID: 22952075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acoustic startle response and sensorimotor gating in a genetic mouse model for the Y1 receptor.
    Karl T; Chesworth R; Duffy L; Herzog H
    Neuropeptides; 2010 Jun; 44(3):233-9. PubMed ID: 20096928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prepulse inhibition and P50 suppression are both deficient but not correlated in schizophrenia patients.
    Braff DL; Light GA; Swerdlow NR
    Biol Psychiatry; 2007 May; 61(10):1204-7. PubMed ID: 17161386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cortisol rapidly disrupts prepulse inhibition in healthy men.
    Richter S; Schulz A; Zech CM; Oitzl MS; Daskalakis NP; Blumenthal TD; Schächinger H
    Psychoneuroendocrinology; 2011 Jan; 36(1):109-14. PubMed ID: 20685043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation of antipsychotic and relative drugs using disruption of prepulse inhibition as an animal model for schizophrenia].
    Suemaru K; Kohnomi S; Umeda K; Araki H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Jun; 28(3):121-6. PubMed ID: 18646597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective breeding for deficient sensorimotor gating is accompanied by increased perseveration in rats.
    Freudenberg F; Dieckmann M; Winter S; Koch M; Schwabe K
    Neuroscience; 2007 Sep; 148(3):612-22. PubMed ID: 17693035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "Typical" but not "atypical" antipsychotic effects on startle gating deficits in prepubertal rats.
    Martinez ZA; Platten A; Pollack E; Shoemaker J; Ro H; Pitcher L; Geyer MA; Swerdlow NR
    Psychopharmacology (Berl); 2002 Apr; 161(1):38-46. PubMed ID: 11967629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterizations of memantine-induced disruption of prepulse inhibition of the acoustic startle response in mice: involvement of dopamine D2 and 5-HT2A receptors.
    Nakaya K; Nakagawasai O; Arai Y; Onogi H; Sato A; Niijima F; Tan-No K; Tadano T
    Behav Brain Res; 2011 Mar; 218(1):165-73. PubMed ID: 21130810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prepulse inhibition and P50 suppression: commonalities and dissociations.
    Oranje B; Geyer MA; Bocker KB; Leon Kenemans J; Verbaten MN
    Psychiatry Res; 2006 Aug; 143(2-3):147-58. PubMed ID: 16879870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of L-theanine on sensorimotor gating in healthy human subjects.
    Ota M; Wakabayashi C; Matsuo J; Kinoshita Y; Hori H; Hattori K; Sasayama D; Teraishi T; Obu S; Ozawa H; Kunugi H
    Psychiatry Clin Neurosci; 2014 May; 68(5):337-43. PubMed ID: 24372613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis.
    Swerdlow NR; Bhakta S; Chou HH; Talledo JA; Balvaneda B; Light GA
    Neuropsychopharmacology; 2016 Jan; 41(2):419-30. PubMed ID: 26062785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.